Using UNC's expertise to fight emerging diseases

Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related: Campus Connections

Archaeological digs at UNC's New East yield centuries-old relics
On a sunny morning in late April, a group of North Carolina faculty and students hunched down on the ground outside New East and sifted...
Wed Nov 12, 2025

James Blizzard is living out his Carolina dream
When James Rolf Blizzard ’24 was 5 years old, his dad took him to a Carolina basketball game at the Smith Center. There Rolf Blizzard...
Mon Nov 10, 2025

Carolina Brewery Celebrates 30 Years
Few Tar Heels have a pedigree as lengthy as Robert Poitras, a fourth-generation UNC alum who grew up tailgating at Kenan Stadium and cheering on...
Sun Nov 9, 2025

Meet 10 Tar Heel military heroes
UNC has a longstanding history of supporting veterans on campus. Before or after they served their country, they spent time in Chapel Hill learning from...
Sat Nov 8, 2025